Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
14 8월 2021 - 6:03AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS
UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission
File Number: 001-37521
INTEC
PHARMA LTD.
(Exact
name of registrant as specified in its charter)
12
Hartom Street
Har
Hotzvim, Jerusalem 9777512
+972-2-586-4657
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Ordinary
Shares, no par value
Warrants to purchase Ordinary Shares
(Title
of each class of securities covered by this Form)
N/A
(Titles
of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule
12g-4(a)(1) ☒
Rule
12g-4(a)(2) ☐
Rule
12h-3(b)(1)(i) ☒
Rule
12h-3(b)(1)(ii) ☐
Rule
15d-6 ☐
Rule
15d-22(b) ☐
Approximate
number of holders of record as of the certification or notice date: Ordinary Shares: One (1); Warrants to purchase Ordinary Shares:
Thirty Two (32)
Pursuant
to the requirements of the Securities Exchange Act of 1934, Intec Pharma Ltd. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
Date:
August 13, 2021
|
By:
|
/s/
Nir Sassi
|
|
|
Nir
Sassi
|
|
|
Chief
Financial Officer
|
Intec Parent (NASDAQ:NTEC)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Intec Parent (NASDAQ:NTEC)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Intec Parent Inc (나스닥)의 실시간 뉴스: 최근 기사 0
More Intec Pharma Ltd. News Articles